Weekly Digest – March 2025 Weekly Digest – March 2025 10 Mar 2025: Kelun-Biotech’s TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) approved for marketing in second indication by NMPA for EGFRm NSCLC • Sichuan Kelun-Biotech’s TROP2-directed ADC, sac-TMT, is now approved in […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id